AZ Sint-Jan Brugge-Oostende — Bruges

Public research footprint of AZ Sint-Jan Brugge-Oostende, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diabetes Mellitus · Chronic Obstructive Pulmonary Disease (COPD) · Non-valvular Atrial Fibrillation · Urinary Bladder Neoplasms

Recently updated registry entries

NCT05159492 — Ground-Breaking Electroporation-based Intervention for PAROXysmal Atrial Fibrillation… (Completed)
NCT04658862 — A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in… (Active Not Recruiting)
NCT05747794 — Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in… (Terminated)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at AZ Sint-Jan Brugge-Oostende?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.